Literature DB >> 32115736

Determination of free clindamycin, flucloxacillin or tedizolid in plasma: Pay attention to physiological conditions when using ultrafiltration.

Christoph Dorn1, Selina Schießer2, Beatrix Wulkersdorfer3, Florian Hitzenbichler2, Martin G Kees4, Markus Zeitlinger3.   

Abstract

Pharmacokinetic/pharmacodynamic indices of anti-infective drugs should be referenced to free drug concentrations. In the present study, clindamycin, flucloxacillin and tedizolid have been determined in human plasma by HPLC-UV. The drugs were separated isocratically within 3-6 min on a C18 column using mixtures of phosphate buffer-acetonitrile of pH 7.1-7.2. Sample treatment for the determination of total drug concentrations in plasma included extraction/back-extraction (clindamycin) or protein precipitation (flucloxacillin, tedizolid). The free drug concentrations were determined after ultrafiltration. An ultrafiltration device with a membrane consisting of regenerated cellulose proved to be suitable for all drugs. Maintaining a physiological pH was crucial for clindamycin, whereas maintaining body temperature was essential for tedizolid. The methods were applied to the analysis of total and free drug concentrations in clinical samples and were sufficiently sensitive for pharmacokinetic studies and therapeutic drug monitoring.
© 2020 The Authors. Biomedical Chromatography published by John Wiley & Sons Ltd.

Entities:  

Keywords:  HPLC-UV; lincosamide; oxazolidinone; penicillin; protein binding; therapeutic drug monitoring

Mesh:

Substances:

Year:  2020        PMID: 32115736     DOI: 10.1002/bmc.4820

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  3 in total

Review 1.  Clinical Pharmacokinetics and Pharmacodynamics of Cefepime.

Authors:  Gwendolyn M Pais; Jack Chang; Erin F Barreto; Gideon Stitt; Kevin J Downes; Mohammad H Alshaer; Emily Lesnicki; Vaidehi Panchal; Maria Bruzzone; Argyle V Bumanglag; Sara N Burke; Marc H Scheetz
Journal:  Clin Pharmacokinet       Date:  2022-06-29       Impact factor: 5.577

2.  Development of a simple method for measuring tedizolid concentration in human serum using HPLC with a fluorescent detector.

Authors:  Yasuhiro Tsuji; Miki Numajiri; Chika Ogami; Fumihiro Kurosaki; Aoi Miyamoto; Takahiko Aoyama; Hitoshi Kawasuji; Kentaro Nagaoka; Yoshiaki Matsumoto; Hideto To; Yoshihiro Yamamoto
Journal:  Medicine (Baltimore)       Date:  2021-12-10       Impact factor: 1.817

Review 3.  Importance and Reality of TDM for Antibiotics Not Covered by Insurance in Japan.

Authors:  Fumiya Ebihara; Yukihiro Hamada; Hideo Kato; Takumi Maruyama; Toshimi Kimura
Journal:  Int J Environ Res Public Health       Date:  2022-02-22       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.